Inpatient use of mobile continuous telemetry for COVID-19 patients treated with hydroxychloroquine and azithromycin
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The current COVID-19 pandemic has placed extreme stress on the global health care system. Novel approaches to managing COIVD-19 patients are required. Preliminary results from a small trial suggest that a combination of hydroxychloroquine and azithromycin is efficacious for reducing the viral load in patients with COVID-19.1 Although the arrhythmogenic risk of these medications is low, both of these medications alone, and in combination, can prolong the QT interval.1–7 Patients receiving this regimen require, at a minimum, serial electrocardiograms (ECGs), which increases the risk of potential exposures for staff members and requires use of additional personal protective equipment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug induced QT prolongation and torsades de pointes
Yap, Y. G., & Camm, A. J. (2003) · Heart · doi:10.1136/heart.89.11.1363 · Cited by 958
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Colson, P., Rolain, J.-M., Lagier, J.-C., Brouqui, P., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105932 · Cited by 937 · cited 1×
“[8] [9] [10] In a similar fashion to hydroxychloroquine and azithromycin, chloroquine also can lead to QT prolongation.”
Cited by
Wearable Sensing and Telehealth Technology with Potential Applications in the Coronavirus Pandemic
Ding, X., Clifton, D., Ji, N., Lovell, N. H., Bonato, P., Chen, W., Yu, X., Xue, Z., Xiang, T., Long, X., et al. (2021) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2020.2992838 · Cited by 281
“to monitor the ECG changes of patients treated with hydroxychloroquine and azithromycin [74].”
BackgroundThe Rise of Wearable Devices during the COVID-19 Pandemic: A Systematic Review
Channa, A., Popescu, N., Skibinska, J., & Burget, R. (2021) · Sensors · doi:10.3390/s21175787 · Cited by 209
A scope of mobile health solutions in COVID-19 pandemics
Asadzadeh, A., & Kalankesh, L. R. (2021) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2021.100558 · Cited by 83
“[29] New York Mobile continuous telemetry • Monitoring cardiac arrhythmias among inpatients with COVID-19”
Metadata
- Authors
- Gabriels, J., Saleh, M., Chang, D., & Epstein, L. M.
- Venue
- HeartRhythm Case Reports
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 6
- Issue
- 5
- Pages
- 241-243
- ISSN
- 2214-0271 (ISSN-L)
- OpenAlex
- W3013939325
- Cited by
- 40
- References
- 2
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inpatient use of mobile continuous telemetry for COVID-19 patients treated with hydroxychloroquine and azithromycin. https://app.cochat.ai/papers/10.1016/j.hrcr.2020.03.017
- The paper
- Gabriels, J., Saleh, M., Chang, D., & Epstein, L. M. (2020). Inpatient use of mobile continuous telemetry for COVID-19 patients treated with hydroxychloroquine and azithromycin. HeartRhythm Case Reports. https://doi.org/10.1016/j.hrcr.2020.03.017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.